Sai Capital Limited has released its unaudited standalone and consolidated financial results for the first quarter of FY27, ended June 30, 2026. The Board of Directors approved the figures during a meeting convened on August 13, 2026.

The company published the results in compliance with Regulation 30 read with Regulation 47, as amended, of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The announcement was made on August 14, 2026.

Disclosures

The financial results were published in the following newspapers:

• Delhi Edition of Financial Express dated August 14, 2026
• Delhi Edition of Jansatta dated August 14, 2026

The complete financial statements, along with the limited review reports issued by the statutory auditors, are accessible on the company’s website at http://www.saicapital.co.in/share-holders.aspx . Investors can also access the documents by scanning the Quick Response Code provided in the original announcement.

Dr. Niraj Kumar Singh, Chairman and Managing Director, signed the communication addressed to the Corporate Relationship Department of BSE Limited.

Sai Capital Limited reported a consolidated net profit of ₹1,255.69 Lacs for the financial year ended March 31, 2026 (FY26), an increase of 15.85% from ₹1,083.83 Lacs in FY25. The growth was driven by a rise in other income to ₹2,386.93 Lacs, despite operational revenue remaining modest at ₹66.64 Lacs. While the group delivered profitability, the standalone entity recorded a net loss of ₹68.23 Lacs against a loss of ₹69.63 Lacs in the previous year. Shareholders will vote on the re-appointment of Chairman and Managing Director Dr. Niraj Kumar Singh and Director Mr. Ankur Rawat at the 31st Annual General Meeting (AGM) scheduled for August 25, 2026.

The Board of Directors recommended Dr. Niraj Kumar Singh’s re-appointment for a five-year term from June 25, 2027, to June 24, 2032. This requires shareholder approval via special resolution under Section 196(3)(a) of the Companies Act, 2013, as he will exceed the age of seventy during this tenure. Mr. Ankur Rawat retires by rotation and offers himself for re-appointment as a Non-Executive, Non-Independent Director. The AGM will be conducted through Video Conferencing or Other Audio Visual Means (VC/OAVM).

Financial Performance

Consolidated revenue from operations increased to ₹66.64 Lacs in FY26 from ₹53.11 Lacs in FY25. Total income rose to ₹2,453.57 Lacs, primarily supported by other income which grew to ₹2,386.93 Lacs from ₹2,287.69 Lacs. Total expenses decreased to ₹628.01 Lacs from ₹700.55 Lacs, contributing to the higher profit before tax of ₹1,825.56 Lacs.

On a standalone basis, the company reported no revenue from operations. Total expenses stood at ₹68.23 Lacs, comprising finance costs of ₹39.30 Lacs and employee benefits of ₹9.36 Lacs. The standalone net loss narrowed slightly to ₹68.23 Lacs from ₹69.63 Lacs.

Key Governance Updates

Dr. Niraj Kumar Singh holds 138,600 equity shares (4.81%) and attended all five board meetings in FY26. Mr. Ankur Rawat, who holds no shares, attended two out of five meetings. The company has appointed Ms. Ritu Mahajan, Practising Company Secretary, as the Scrutinizer for the e-voting process. Remote e-voting begins on August 22, 2026, and closes on August 24, 2026.

What the Numbers Show

The divergence between standalone and consolidated results highlights the group’s reliance on subsidiary performance for profitability. While the holding company incurred losses driven by finance costs on unsecured borrowings of ₹499.08 Lacs, the subsidiaries generated significant other income. This structure suggests that value creation is concentrated within the subsidiary entities, particularly Health Care Energy Foods Private Limited and Butterfly Ayurveda Private Limited, rather than the parent entity’s direct operations.